Why the study?
Cardiovascular diseases cause significant global mortality, making early detection crucial, leading researchers to examine whether Pro-neurotensin and Heart-type fatty acid binding protein serve as dependable biomarkers in cardiac patients with heart failure.
Do serum ProNT and H-FABP levels accurately diagnose cardiovascular diseases, specifically heart failure, in symptomatic patients?
Do serum ProNT and H-FABP levels accurately diagnose cardiovascular diseases, specifically heart failure, in symptomatic patients?
Elevated ProNT and H-FABP levels show high sensitivity and specificity, suggesting their potential as reliable diagnostic biomarkers for patients with heart failure.
Answers are grounded in this paper and cite their sources.
May support diagnostic use in symptomatic heart failure; leaves open prospective validation before clinical adoption.
AIM: In 2019, cardiovascular diseases accounted for 32% of global deaths. So, early detection of cardiac disorders is crucial. The study aimed to examine the suitability of Pro-neurotensin and Heart-type fatty acid binding protein as dependable biomarkers for cardiac patients with Heart failure as a primary diagnosis. METHODOLOGY: The prospective study involved 204 Egyptian volunteers (100 cardiac patients and 104 controls) enrolled from El-Sahel Teaching Hospital in Cairo, Egypt, between October 2022 and May 2023. Inclusion criteria included a high risk of cardiovascular events with symptoms like a fast or irregular pulse, shortness of breath, and fatigue. Exclusion criteria included asymptomatic individuals, cognitive disorders, and psychiatric conditions. The Research Ethics Committee approved the protocol. The consultant conducted a clinical examination of all patients and assessed their heart state. Serum ProNT and H-FABP were detected using a kit for the sandwich ELISA technique. Demonstrated sensitivity of 81% and 84%, with a specificity of 89% and 91%, respectively. CONCLUSION: Elevated ProNT and H-FABP levels are associated with severe CVDs, suggesting their potential as diagnostic biomarkers for patients, specifically those with heart failure, as a primary characteristic.
No takes yet. Share an insight, caveat, or question.
Elzantout et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: